{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:42:44Z","timestamp":1780051364860,"version":"3.53.1"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100007405","name":"Danish Heart Foundation","doi-asserted-by":"publisher","award":["19-R134-A8959-22123"],"award-info":[{"award-number":["19-R134-A8959-22123"]}],"id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>There is no consensus on whether biological differences account for the higher risk of stroke seen in females compared to males with atrial fibrillation (AF).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>Capitalizing on The Losartan Intervention for Endpoint study, a multicenter randomized clinical trial randomizing 9,193 patients and followed for at least four years, we aimed to identify sex differences in the risk of stroke in the presence of AF in patients with hypertension and left ventricular hypertrophy (LVH).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>342 Patients had a history of AF, and 669 developed new-onset AF. History of AF and new-onset AF were more prevalent among males (5.0% vs. 2.9% and 3.0% vs. 0.9%) in patients aged 55\u201363 years, but the relative difference decreased with age. Females with new-onset AF tended to have a higher risk of stroke than males (HR 1.52 [95% CI 0.95\u20132.43]). However, females with a history of AF did not have a higher risk than males (HR 0.88 [95% CI 0.5\u20131.6]). In patients with new-onset AF, the relative higher stroke risk in females increased with age. Among patients with a history of AF, stroke risk was comparable and increased with age in both sexes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Among patients with hypertension and LVH, females with new-onset AF had a higher risk of stroke than males, especially in patients above 64 years. However, the risk did not differ between the sexes among patients with a history of AF.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajh\/hpad057","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T10:14:17Z","timestamp":1688033657000},"page":"536-541","source":"Crossref","is-referenced-by-count":5,"title":["Sex Differences in Atrial Fibrillation and Associated Complications in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study"],"prefix":"10.1093","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1975-9300","authenticated-orcid":false,"given":"Joshua B","family":"Feinberg","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Cardiology Section, Holbaek Hospital , Holbaek , Denmark"},{"name":"Department of Regional Health Research, The Faculty of Health Sciences, University of Southern Denmark , Odense , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil E","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cardiology Section, Holbaek Hospital , Holbaek , Denmark"},{"name":"Department of Regional Health Research, The Faculty of Health Sciences, University of Southern Denmark , Odense , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sverre E","family":"Kjeldsen","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Ullevaal Hospital, University of Oslo , Oslo , Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B","family":"Devereux","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Weill Cornell Medicine , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4109-2311","authenticated-orcid":false,"given":"Eva","family":"Gerdts","sequence":"additional","affiliation":[{"name":"Department of Clinical Science, University of Bergen , Bergen , Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Wachtell","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Weill Cornell Medicine , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H","family":"Olsen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cardiology Section, Holbaek Hospital , Holbaek , Denmark"},{"name":"Department of Regional Health Research, The Faculty of Health Sciences, University of Southern Denmark , Odense , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"key":"2023091509381978700_CIT0001","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrcardio.2016.45","article-title":"Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis","volume":"13","author":"Ko","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"2023091509381978700_CIT0002","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2174\/1573403X15666181205110624","article-title":"Gender differences in atrial fibrillation: a review of epidemiology, management, and outcomes","volume":"15","author":"Westerman","year":"2019","journal-title":"Curr Cardiol Rev"},{"key":"2023091509381978700_CIT0003","doi-asserted-by":"crossref","first-page":"e006350","DOI":"10.1161\/CIRCEP.118.006350","article-title":"Lifetime risk of atrial fibrillation by race and socioeconomic status: ARIC Study (atherosclerosis risk in communities)","volume":"11","author":"Mou","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2023091509381978700_CIT0004","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"key":"2023091509381978700_CIT0005","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0140-6736(16)30968-0","article-title":"Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study","volume":"388","author":"Healey","year":"2016","journal-title":"Lancet (London, England)"},{"key":"2023091509381978700_CIT0006","first-page":"h7013","article-title":"Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies","volume":"532","author":"Emdin","year":"2016","journal-title":"BMJ (Clin Res Ed)"},{"issue":"5","key":"2023091509381978700_CIT0007","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021  1","journal-title":"Eur Heart J."},{"key":"2023091509381978700_CIT0008","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/europace\/euy215","article-title":"Mechanisms of sex differences in atrial fibrillation: role of hormones and differences in electrophysiology, structure, function, and remodelling","volume":"21","author":"Odening","year":"2019","journal-title":"Europace"},{"key":"2023091509381978700_CIT0009","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0002-9149(01)01433-3","article-title":"Gender differences in systolic left ventricular function in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study)","volume":"87","author":"Gerdts","year":"2001","journal-title":"Am J Cardiol"},{"key":"2023091509381978700_CIT0010","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0895-7061(97)88956-X","article-title":"The Losartan Intervention For Endpoint reduction (LIFE) in hypertension study: rationale, design, and methods. The LIFE Study Group","volume":"10","author":"Dahl\u00f6f","year":"1997","journal-title":"Am J Hypertens"},{"key":"2023091509381978700_CIT0011","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahl\u00f6f","year":"2002","journal-title":"Lancet"},{"key":"2023091509381978700_CIT0012","volume-title":"Stata Statistical Software: Release 17","author":"StataCorp","year":"2021"},{"key":"2023091509381978700_CIT0013","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/HYPERTENSIONAHA.107.107474","article-title":"Gender differences in left ventricular structure and function during antihypertensive treatment: the Losartan Intervention for Endpoint Reduction in Hypertension Study","volume":"51","author":"Gerdts","year":"2008","journal-title":"Hypertension"},{"key":"2023091509381978700_CIT0014","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1161\/01.HYP.0000254322.96189.85","article-title":"Left atrial size and risk of major cardiovascular events during antihypertensive treatment: Losartan intervention for endpoint reduction in hypertension trial","volume":"49","author":"Gerdts","year":"2007","journal-title":"Hypertension"},{"key":"2023091509381978700_CIT0015","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","article-title":"Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study","volume":"271","author":"Benjamin","year":"1994","journal-title":"JAMA"},{"key":"2023091509381978700_CIT0016","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/heartjnl-2016-310406","article-title":"Gender differences in clinical presentation and 1-year outcomes in atrial fibrillation","volume":"103","author":"Schnabel","year":"2017","journal-title":"Heart"},{"issue":"14","key":"2023091509381978700_CIT0017","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020  1","journal-title":"N Engl J Med"},{"key":"2023091509381978700_CIT0018","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/qjmed\/hcu054","article-title":"Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis","volume":"107","author":"Wagstaff","year":"2014","journal-title":"QJM"},{"key":"2023091509381978700_CIT0019","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jacep.2018.01.014","article-title":"Comparing management and outcomes in men and women with non-valvular atrial fibrillation: data from a population-based cohort","volume":"4","author":"Arnson","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"2023091509381978700_CIT0020","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/01.CIR.0000141573.44737.5A","article-title":"Regression of hypertensive left ventricular hypertrophy by Losartan compared with atenolol","volume":"110","author":"Devereux","year":"2004","journal-title":"Circulation"},{"key":"2023091509381978700_CIT0021","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"}],"container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajh\/advance-article-pdf\/doi\/10.1093\/ajh\/hpad057\/50855827\/hpad057.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/36\/10\/536\/51272955\/hpad057.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/36\/10\/536\/51272955\/hpad057.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T13:54:45Z","timestamp":1694786085000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajh\/article\/36\/10\/536\/7210137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":21,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,6,29]]},"published-print":{"date-parts":[[2023,9,15]]}},"URL":"https:\/\/doi.org\/10.1093\/ajh\/hpad057","relation":{},"ISSN":["0895-7061","1941-7225"],"issn-type":[{"value":"0895-7061","type":"print"},{"value":"1941-7225","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,10,1]]},"published":{"date-parts":[[2023,6,29]]}}}